Apoptosis(凋亡)
As one of the cellular death mechanisms, apoptosis, also known as programmed cell death, can be defined as the process of a proper death of any cell under certain or necessary conditions. Apoptosis is controlled by the interactions between several molecules and responsible for the elimination of unwanted cells from the body.
Many biochemical events and a series of morphological changes occur at the early stage and increasingly continue till the end of apoptosis process. Morphological event cascade including cytoplasmic filament aggregation, nuclear condensation, cellular fragmentation, and plasma membrane blebbing finally results in the formation of apoptotic bodies. Several biochemical changes such as protein modifications/degradations, DNA and chromatin deteriorations, and synthesis of cell surface markers form morphological process during apoptosis.
Apoptosis can be stimulated by two different pathways: (1) intrinsic pathway (or mitochondria pathway) that mainly occurs via release of cytochrome c from the mitochondria and (2) extrinsic pathway when Fas death receptor is activated by a signal coming from the outside of the cell.
Different gene families such as caspases, inhibitor of apoptosis proteins, B cell lymphoma (Bcl)-2 family, tumor necrosis factor (TNF) receptor gene superfamily, or p53 gene are involved and/or collaborate in the process of apoptosis.
Caspase family comprises conserved cysteine aspartic-specific proteases, and members of caspase family are considerably crucial in the regulation of apoptosis. There are 14 different caspases in mammals, and they are basically classified as the initiators including caspase-2, -8, -9, and -10; and the effectors including caspase-3, -6, -7, and -14; and also the cytokine activators including caspase-1, -4, -5, -11, -12, and -13. In vertebrates, caspase-dependent apoptosis occurs through two main interconnected pathways which are intrinsic and extrinsic pathways. The intrinsic or mitochondrial apoptosis pathway can be activated through various cellular stresses that lead to cytochrome c release from the mitochondria and the formation of the apoptosome, comprised of APAF1, cytochrome c, ATP, and caspase-9, resulting in the activation of caspase-9. Active caspase-9 then initiates apoptosis by cleaving and thereby activating executioner caspases. The extrinsic apoptosis pathway is activated through the binding of a ligand to a death receptor, which in turn leads, with the help of the adapter proteins (FADD/TRADD), to recruitment, dimerization, and activation of caspase-8 (or 10). Active caspase-8 (or 10) then either initiates apoptosis directly by cleaving and thereby activating executioner caspase (-3, -6, -7), or activates the intrinsic apoptotic pathway through cleavage of BID to induce efficient cell death. In a heat shock-induced death, caspase-2 induces apoptosis via cleavage of Bid.
Bcl-2 family members are divided into three subfamilies including (i) pro-survival subfamily members (Bcl-2, Bcl-xl, Bcl-W, MCL1, and BFL1/A1), (ii) BH3-only subfamily members (Bad, Bim, Noxa, and Puma9), and (iii) pro-apoptotic mediator subfamily members (Bax and Bak). Following activation of the intrinsic pathway by cellular stress, pro‑apoptotic BCL‑2 homology 3 (BH3)‑only proteins inhibit the anti‑apoptotic proteins Bcl‑2, Bcl-xl, Bcl‑W and MCL1. The subsequent activation and oligomerization of the Bak and Bax result in mitochondrial outer membrane permeabilization (MOMP). This results in the release of cytochrome c and SMAC from the mitochondria. Cytochrome c forms a complex with caspase-9 and APAF1, which leads to the activation of caspase-9. Caspase-9 then activates caspase-3 and caspase-7, resulting in cell death. Inhibition of this process by anti‑apoptotic Bcl‑2 proteins occurs via sequestration of pro‑apoptotic proteins through binding to their BH3 motifs.
One of the most important ways of triggering apoptosis is mediated through death receptors (DRs), which are classified in TNF superfamily. There exist six DRs: DR1 (also called TNFR1); DR2 (also called Fas); DR3, to which VEGI binds; DR4 and DR5, to which TRAIL binds; and DR6, no ligand has yet been identified that binds to DR6. The induction of apoptosis by TNF ligands is initiated by binding to their specific DRs, such as TNFα/TNFR1, FasL /Fas (CD95, DR2), TRAIL (Apo2L)/DR4 (TRAIL-R1) or DR5 (TRAIL-R2). When TNF-α binds to TNFR1, it recruits a protein called TNFR-associated death domain (TRADD) through its death domain (DD). TRADD then recruits a protein called Fas-associated protein with death domain (FADD), which then sequentially activates caspase-8 and caspase-3, and thus apoptosis. Alternatively, TNF-α can activate mitochondria to sequentially release ROS, cytochrome c, and Bax, leading to activation of caspase-9 and caspase-3 and thus apoptosis. Some of the miRNAs can inhibit apoptosis by targeting the death-receptor pathway including miR-21, miR-24, and miR-200c.
p53 has the ability to activate intrinsic and extrinsic pathways of apoptosis by inducing transcription of several proteins like Puma, Bid, Bax, TRAIL-R2, and CD95.
Some inhibitors of apoptosis proteins (IAPs) can inhibit apoptosis indirectly (such as cIAP1/BIRC2, cIAP2/BIRC3) or inhibit caspase directly, such as XIAP/BIRC4 (inhibits caspase-3, -7, -9), and Bruce/BIRC6 (inhibits caspase-3, -6, -7, -8, -9).
Any alterations or abnormalities occurring in apoptotic processes contribute to development of human diseases and malignancies especially cancer.
References:
1.Yağmur Kiraz, Aysun Adan, Melis Kartal Yandim, et al. Major apoptotic mechanisms and genes involved in apoptosis[J]. Tumor Biology, 2016, 37(7):8471.
2.Aggarwal B B, Gupta S C, Kim J H. Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey.[J]. Blood, 2012, 119(3):651.
3.Ashkenazi A, Fairbrother W J, Leverson J D, et al. From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors[J]. Nature Reviews Drug Discovery, 2017.
4.McIlwain D R, Berger T, Mak T W. Caspase functions in cell death and disease[J]. Cold Spring Harbor perspectives in biology, 2013, 5(4): a008656.
5.Ola M S, Nawaz M, Ahsan H. Role of Bcl-2 family proteins and caspases in the regulation of apoptosis[J]. Molecular and cellular biochemistry, 2011, 351(1-2): 41-58.
Products for Apoptosis
- Caspase(99)
- 14.3.3 Proteins(1)
- Apoptosis Inducers(43)
- Bax(7)
- Bcl-2 Family(120)
- Bcl-xL(8)
- c-RET(9)
- IAP(27)
- KEAP1-Nrf2(66)
- MDM2(12)
- p53(123)
- PC-PLC(4)
- PKD(7)
- RasGAP (Ras- P21)(1)
- Survivin(8)
- Thymidylate Synthase(10)
- TNF-α(145)
- Other Apoptosis(883)
- APC(6)
- PD-1/PD-L1 interaction(90)
- ASK1(3)
- PAR4(2)
- RIP kinase(52)
- FKBP(20)
- Pyroptosis(31)
- Cat.No. 产品名称 Information
-
GC49429
6-keto Lithocholic Acid
3Α-羟基-6K-5Β-胆甾烷-24-酸
A metabolite of lithocholic acid -
GC49426
Taurine-d4
牛磺酸-D4,2-Aminoethanesulfonic acid-d4
An internal standard for the quantification of taurine -
GC49425
Simazine-d10
十氘代西玛嗪
An internal standard for the quantification of simazine -
GC49415
Capsorubin
辣椒紫紅素
A carotenoid with diverse biological activities -
GC49412
NSC 756093
An inhibitor of the GBP1-Pim-1 protein-protein interaction
-
GC49403
Benzarone
苯扎隆,Fragivix
An active metabolite of benzbromarone -
GC49401
Triptolide-d3
PG490-d3
Triptolide-d3 (PG490-d3) 是氘标记的雷公藤内酯。雷公藤内酯是从雷公藤根中提取的二萜类三环氧化物,具有免疫抑制、抗炎、抗增殖和抗肿瘤作用。雷公藤内酯是一种 NF-κB 活化抑制剂。 -
GC49393
all-trans-13,14-Dihydroretinol
A metabolite of all-trans retinoic acid
-
GC49372
Kaempferol 7-neohesperidoside
山柰酚-7-O-新橙皮糖苷
A flavonoid glycoside with antioxidant and anticancer activities -
GC49344
Fisetin-d5
An internal standard for the quantification of fisetin
-
GC49329
Turkesterone (hydrate)
A phytoecdysteroid with diverse biological activities
-
GC49314
Arecaidine propargyl ester (hydrobromide)
1,2,5,6-四氢-1-甲基-3-吡啶羧酸2-丙炔-1-基酯氢溴酸盐
A muscarinic M2 agonist -
GC49308
Ungeremine
石蒜碱内铵盐
A betaine-type alkaloid with diverse biological activities -
GC49303
Ganoderic Acid DM
灵芝酸 DM
A triterpenoid with diverse biological activities -
GC49275
8-Oxycoptisine
8-氧黄连碱
An isoquinoline alkaloid with anticancer and gastroprotective activities -
GC49270
Nicotinamide-d4
氘代烟酰胺,Niacinamide-d4; Nicotinic acid amide-d4
An internal standard for the quantification of nicotinamide -
GC49268
(+)-δ-Cadinene
Δ-杜松烯
A sesquiterpene with antimicrobial and anticancer activities -
GC49259
Antagonist G (trifluoroacetate salt)
Arg-D-Trp-NmePhe-D-Trp-Leu-Met-NH2, Arg6,D-Trp7,9,NmePhe8-substance P (6-11)
A neuropeptide antagonist -
GC49251
Oxaliplatin-d10
Lipoxal-d10
An internal standard for the quantification of oxaliplatin -
GC49228
Ganoderol B
灵芝醇 B; Ganodermadiol
A triterpenoid with diverse biological activities -
GC49223
2-deoxy-D-Glucose-13C6
2-DG-13C6
An internal standard for the quantification of 2-deoxy-D-glucose -
GC49221
QLT0267
An ILK inhibitor
-
GC49189
(E/Z)-4-hydroxy Tamoxifen-d5
Afimoxifene-d5, 4-OHT-d5
An internal standard for the quantification of (E/Z)-4-hydroxy tamoxifen -
GC49177
Loliolide
地芰普内酯
A monoterpene lactone with diverse biological activities -
GC49168
Visnagin
齿阿米素
A furanochromone with diverse biological activities -
GC49164
DM4 (hydrate)
Maytansinoid DM 4
A derivative of maytansine -
GC49155
K6PC-5
An SPHK1 activator
-
GC49153
Didemnin B
NSC 325319, NSC 333841
Didemnin B 是一种由海洋被囊类动物产生的环状肽肽,可特异性结合 EEF1A 的 GTP 结合构象,抑制其从核糖体 A 位点释放并防止随后的肽延伸。 -
GC49152
Celecoxib Carboxylic Acid
羧酸塞来昔布
An inactive metabolite of celecoxib -
GC49147
Carboxyphosphamide
CPCOOH, NSC 145124
An inactive metabolite of cyclophosphamide -
GC49137
Triclabendazole-13C-d3
CGA89317-13C,d3
An internal standard for the quantification of triclabendazole -
GC49130
Hydroxy Celecoxib
羟甲基塞来昔布
An inactive metabolite of celecoxib -
GC49127
4-oxo Cyclophosphamide
4-keto CP, 4-keto Cyclophosphamide, NSC 139488, 4-oxo CP
An inactive metabolite of cyclophosphamide -
GC49126
Folitixorin
5,10-亚甲基四氢叶酸(非对映体混合物),5,10-Methylenetetrafolate; ANX-510 free acid
Folitixorin是叶酸的一种还原形式,也是胸苷酸合成酶的辅助因子。 -
GC49096
Cobaltic Protoporphyrin IX (chloride)
原卟啉氯化钴
An inducer of HO-1 activity -
GC49084
PHY34
An inhibitor of late-stage autophagy
-
GC49080
CAY10786
GPR52-IN-43
A GPR52 antagonist -
GC49055
Tebuconazole-d9
戊唑醇 d9
An internal standard for the quantification of tebuconazole -
GC49042
Benastatin A
A bacterial metabolite with diverse biological activities
-
GC49024
Palmitic Acid MaxSpec® Standard
棕榈酸
A long-chain saturated fatty acid -
GC49023
Palmitic Acid-d9 MaxSpec® Standard
棕榈酸-13,13,14,14,15,15,16,16,16-D9
A quantitative analytical standard guaranteed to meet MaxSpec identity, purity, stability, and concentration specifications -
GC49015
Phenethyl isothiocyanate
2-苯基乙基异硫代氰酸酯
An isothiocyanate with anticancer activity -
GC48974
Ac-VEID-AMC (ammonium acetate salt)
NAcetylValGluIleAsp7amido4Methylcoumarin, Caspase6 Substrate (Fluorogenic)
A caspase-6 fluorogenic substrate -
GC48971
AZD 1152 (hydrochloride)
5-[[7-[3-[乙基[2-(磷酰氧基)乙基]氨基]丙氧基]-4-喹唑啉基]氨基]-N-(3-氟苯基)-1H-吡唑-3-乙酰胺二盐酸盐
A prodrug for a potent Aurora B inhibitor -
GC19843
Nimbolide
印苦楝内酯
An anticancer phytochemical -
GC62716
MD-222
MD-222 是一种首创的高效的基于 PROTAC 的 MDM2 降解剂。MD-222 诱导 MDM2 蛋白快速降解并激活细胞中的野生型 p53。MD-222 具有抗癌作用。
-
GC62707
Murizatoclax
AMG 397
Murizatoclax (AMG 397) 是一种有效,选择性和具有口服活性的髓样白血病 1 (MCL-1) 抑制剂,Ki 值为 15 pM。Murizatoclax 与促凋亡 BCL-2 家族成员竞争性结合 MCL1 的 BH3 结合沟。Murizatoclax 可用于癌症的研究。 -
GC62693
SCR130
SCR130 is a novel DNA repair inhibitor with IC50s of 14 μM in Reh cells and 2 μM in Nalm6 cells. SCR130 specifically inhibits DNA Ligase IV‐mediated joining with minimal or no effect on Ligase III and Ligase I mediated joining.
-
GC62688
PD-1/PD-L1-IN-8
PD-1/PD-L1-IN-8
INCB086550 (PD-1/PD-L1-IN-8) is potent a PD-1/PD-L1 inhibitor, with an IC50 <= 10 nM.
-
GC62682
BMSpep-57 hydrochloride
BMSpep-57 hydrochloride 是一种有效的大环肽类抑制剂,抑制 PD-1/PD-L1 相互作用,IC50 为 7.68 nM。BMSpep-57 hydrochloride 与 PD-L1 结合,MST 和 SPR 测定表明,Kd 分别为 19 nM 和 19.88 nM。BMSpep-57 hydrochloride 通过增加 PBMC 中 IL-2 的产生促进 T 细胞功能。